...
首页> 外文期刊>Cancer letters >Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancer
【24h】

Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancer

机译:细胞蛋白结合抗癌多硫化物通过在结肠直肠癌中的有丝分裂骤停和自噬干扰来诱导细胞死亡

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Polysulfanes show chemopreventive effects against gastrointestinal tumors. We identified diallyl tetrasulfide and its derivative, dibenzyl tetrasulfide (DBTTS), to be mitotic inhibitors and apoptosis inducers. Here, we translate their application in colorectal cancer (CRC). MALDI-TOF-MS analysis identified both compounds as reversible tubulin binders, validated by in cellulo α-tubulin degradation. BRAF(V600E)-mutated HT-29?cells were resistant to DBTTS, as evidenced by mitotic arrest for 48?h prior to apoptosis induction compared to KRAS(G12V)-mutated SW480/620?cells, which committed to death earlier. The prolonged mitotic block correlated with autophagy impairment and p62 protein accumulation in HT-29 but not in SW480/620?cells, whereas siRNA-mediated p62 inhibition sensitized HT-29?cells to death. In silico analysis with 484 colorectal cancer patients associated higher p62 expression and reduced autophagic flux with greater overall survival. Accordingly, we hypothesized that DBTTS targets CRC survival/death through autophagy interference in cell types with differential autophagic capacities. We confirmed the therapeutic potential of DBTTS by the inhibition of spheroid and colony formation capacities in CRC cells, as well as in HT-29 zebrafish xenografts in?vivo .
机译:摘要多硫丹犬对胃肠道肿瘤进行化学预防作用。我们鉴定了二烯丙基四硫化物及其衍生物,二苄酰丁酰胺(DBTTS),是有丝分裂抑制剂和凋亡的诱导剂。在这里,我们将其在结肠直肠癌(CRC)中的应用翻译。 MALDI-TOF-MS分析将化合物鉴定为可逆微管蛋白粘合剂,通过在纤维素α-管蛋白降解中验证。 BRAF(V600E) - 矫正HT-29?细胞对DBTT进行抗性,如在凋亡诱导之前通过薄膜停滞的有丝分裂停滞器,与KRAS(G12V)封闭的SW480 / 620?细胞,其提前致死。延长的有丝分裂块与HT-29中的自噬损伤和P62蛋白质积累相关,但不在SW480 / 620?细胞中,而siRNA介导的P62抑制致敏HT-29?细胞死亡。在Silico分析中,484结直肠癌患者相关的P62表达和减少的自噬助剂,具有更高的整体存活。因此,我们假设DBTT通过具有差分自噬能量的细胞类型的自噬干扰来靶向CRC生存/死亡。我们通过抑制CRC细胞中的球形和菌落形成容量以及HT-29斑马鱼异种移植物,确认了DBTT的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号